193 related articles for article (PubMed ID: 26708419)
1. The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin.
Kato K; Iwama H; Yamashita T; Kobayashi K; Fujihara S; Fujimori T; Kamada H; Kobara H; Masaki T
Oncol Rep; 2016 Mar; 35(3):1582-92. PubMed ID: 26708419
[TBL] [Abstract][Full Text] [Related]
2. The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo.
Kato K; Gong J; Iwama H; Kitanaka A; Tani J; Miyoshi H; Nomura K; Mimura S; Kobayashi M; Aritomo Y; Kobara H; Mori H; Himoto T; Okano K; Suzuki Y; Murao K; Masaki T
Mol Cancer Ther; 2012 Mar; 11(3):549-60. PubMed ID: 22222629
[TBL] [Abstract][Full Text] [Related]
3. Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.
Miyoshi H; Kato K; Iwama H; Maeda E; Sakamoto T; Fujita K; Toyota Y; Tani J; Nomura T; Mimura S; Kobayashi M; Morishita A; Kobara H; Mori H; Yoneyama H; Deguchi A; Himoto T; Kurokohchi K; Okano K; Suzuki Y; Murao K; Masaki T
Int J Oncol; 2014 Jul; 45(1):322-32. PubMed ID: 24806290
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of metformin in esophageal cancer: in vitro study.
Kobayashi M; Kato K; Iwama H; Fujihara S; Nishiyama N; Mimura S; Toyota Y; Nomura T; Nomura K; Tani J; Miyoshi H; Kobara H; Mori H; Murao K; Masaki T
Int J Oncol; 2013 Feb; 42(2):517-24. PubMed ID: 23229592
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo.
Fujihara S; Kato K; Morishita A; Iwama H; Nishioka T; Chiyo T; Nishiyama N; Miyoshi H; Kobayashi M; Kobara H; Mori H; Okano K; Suzuki Y; Masaki T
Int J Oncol; 2015 May; 46(5):2172-80. PubMed ID: 25709052
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of metformin on cholangiocarcinoma: In vitro and in vivo studies.
Fujimori T; Kato K; Fujihara S; Iwama H; Yamashita T; Kobayashi K; Kamada H; Morishita A; Kobara H; Mori H; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2015 Dec; 34(6):2987-96. PubMed ID: 26398221
[TBL] [Abstract][Full Text] [Related]
7. Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.
Miyoshi H; Kato K; Iwama H; Maeda E; Sakamoto T; Fujita K; Toyota Y; Tani J; Nomura T; Mimura S; Kobayashi M; Morishita A; Kobara H; Mori H; Yoneyama H; Deguchi A; Himoto T; Kurokohchi K; Okano K; Suzuki Y; Murao K; Masaki T
Int J Oncol; 2013 Dec; ():. PubMed ID: 24378856
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of the antidiabetic drug metformin in small bowel adenocarcinoma.
Chiyo T; Kato K; Iwama H; Fujihara S; Fujita K; Tadokoro T; Ohura K; Samukawa E; Yamana Y; Kobayashi N; Matsunaga T; Nishiyama N; Ayaki M; Yachida T; Morishita A; Kobara H; Mori H; Masaki T
Int J Oncol; 2017 Jun; 50(6):2145-2153. PubMed ID: 28440424
[TBL] [Abstract][Full Text] [Related]
9. Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest.
Yamashita T; Kato K; Fujihara S; Iwama H; Morishita A; Yamana H; Kobayashi K; Kamada H; Chiyo T; Kobara H; Tsutsui K; Okano K; Suzuki Y; Masaki T
Anticancer Drugs; 2020 Mar; 31(3):231-240. PubMed ID: 31815765
[TBL] [Abstract][Full Text] [Related]
10. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.
Fujihara S; Morishita A; Ogawa K; Tadokoro T; Chiyo T; Kato K; Kobara H; Mori H; Iwama H; Masaki T
Oncotarget; 2017 Jan; 8(5):8536-8549. PubMed ID: 28052030
[TBL] [Abstract][Full Text] [Related]
11. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.
Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K
Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373
[TBL] [Abstract][Full Text] [Related]
12. Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells.
Li W; Yuan Y; Huang L; Qiao M; Zhang Y
Diabetes Res Clin Pract; 2012 May; 96(2):187-95. PubMed ID: 22245693
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive drug telmisartan suppresses the proliferation of gastric cancer cells in vitro and in vivo.
Fujita N; Fujita K; Iwama H; Kobara H; Fujihara S; Chiyo T; Namima D; Yamana H; Kono T; Takuma K; Hirata M; Kobayashi K; Kato K; Kamada H; Morishita A; Tsutsui K; Himoto T; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2020 Jul; 44(1):339-348. PubMed ID: 32627043
[TBL] [Abstract][Full Text] [Related]
14. Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis.
Yamana H; Kato K; Kobara H; Fujihara S; Fujita K; Namima D; Fujita N; Kobayashi K; Kamada H; Morishita A; Tsutsui K; Iwama H; Masaki T
Anticancer Res; 2020 Jan; 40(1):121-132. PubMed ID: 31892560
[TBL] [Abstract][Full Text] [Related]
15. Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.
Zhao H; Wang L; Wei R; Xiu D; Tao M; Ke J; Liu Y; Yang J; Hong T
Diabetes Obes Metab; 2014 Sep; 16(9):850-60. PubMed ID: 24641303
[TBL] [Abstract][Full Text] [Related]
16. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
[TBL] [Abstract][Full Text] [Related]
17. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.
Ben Sahra I; Laurent K; Loubat A; Giorgetti-Peraldi S; Colosetti P; Auberger P; Tanti JF; Le Marchand-Brustel Y; Bost F
Oncogene; 2008 Jun; 27(25):3576-86. PubMed ID: 18212742
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells.
Yoshida J; Ishikawa T; Endo Y; Matsumura S; Ota T; Mizushima K; Hirai Y; Oka K; Okayama T; Sakamoto N; Inoue K; Kamada K; Uchiyama K; Takagi T; Naito Y; Itoh Y
Oncol Rep; 2020 Jul; 44(1):371-381. PubMed ID: 32627027
[TBL] [Abstract][Full Text] [Related]
19. Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner.
Zhao H; Wei R; Wang L; Tian Q; Tao M; Ke J; Liu Y; Hou W; Zhang L; Yang J; Hong T
Am J Physiol Endocrinol Metab; 2014 Jun; 306(12):E1431-41. PubMed ID: 24801389
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines.
Pino MS; Shrader M; Baker CH; Cognetti F; Xiong HQ; Abbruzzese JL; McConkey DJ
Cancer Res; 2006 Apr; 66(7):3802-12. PubMed ID: 16585207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]